Suggestions
Jonathan Mott
Senior Scientist at FibroGen, Inc.
Professional Background
Jonathan Mott is an accomplished scientist specializing in process development for upstream bioprocessing within the pharmaceutical industry. With extensive experience in several prestigious organizations, Jonathan has honed his expertise in the nuances of biopharmaceutical production, ensuring the highest quality standards are maintained during drug development. Currently serving as a Senior Scientist at FibroGen, Inc., he leads innovative projects centered on developing and optimizing bioprocesses essential to the production of life-saving therapies.
Prior to his current role, Jonathan made significant contributions as a Scientist II at Nektar Therapeutics, where he played a pivotal role in advancing the bioprocessing techniques required for the development of novel therapeutics. His tenure at Nektar also included positions as both Scientist and Associate Scientist, through which he meticulously refined his skills across various stages of drug development, particularly in upstream processing methodologies.
Before his impactful time at Nektar, Jonathan worked as an Upstream Process Development Engineer II at Amunix, further expanding his expertise in upstream processing techniques. His early career includes valuable research and internship experiences at leading biopharmaceutical companies such as AbbVie and Merck, where he actively engaged in high-level research projects. Additionally, he contributed to the academic community as a Research Assistant in the Department of Chemical Engineering, wherein he gained hands-on experience in various experimental methodologies and cutting-edge research initiatives.
Through these experiences, Jonathan has developed a strong foundation in biochemistry and engineering principles, making him a well-respected figure in the biopharmaceutical community.
Education and Achievements
Jonathan Mott is a proud alumnus of Stanford University, where he pursued both his Bachelor's and Master's degrees in Chemical Engineering. His commitment to academic excellence is exemplified by his impressive GPA of 3.790 during his undergraduate study and 3.800 in his master's program, showcasing his determination and analytical skills in one of the most rigorous engineering programs in the world.
At Stanford, Jonathan not only acquired a deep understanding of chemical engineering principles but also engaged in collaborative research projects that built his skills in data analysis, laboratory techniques, and project management. This rigorous educational background provides a solid foundation for his successful career in the pharmaceutical industry.
Achievements
Throughout his career, Jonathan has become adept at managing complex projects and driving innovations in the biopharmaceutical realm. Some of his notable achievements include:
- Leading significant bioprocess development projects that have resulted in enhanced productivity and efficiency for drug manufacturing processes.
- Spearheading initiatives that have successfully optimized upstream bioprocess workflows, substantially reducing time and cost while improving yield and quality of final products.
- Instrumental in the development of processes that comply with regulatory standards, ensuring product safety and efficacy.
- Recognized for his contributions to scientific publications and presentations in industry conferences, establishing him as a thought leader in the field of bioprocess engineering.
Jonathan's blend of practical experience, comprehensive education, and dedication to innovation underscore his status as a leading professional in upstream bioprocessing within the pharmaceutical industry, where he continues to make significant strides.
tags:[
Chemical Engineering
Pharmaceutical Industry
Process Development
Upstream Bioprocessing
Research Professional
Senior Scientist
FibroGen
Nektar Therapeutics
Amunix
AbbVie
Merck
Stanford University
